Skip to main content

Table 3 In-hospital outcomes of patients undergoing tricuspid valve surgery for isolated rheumatic tricuspid regurgitation (n = 26) with comparison between tricuspid valve repair group and tricuspid valve replacement group. Data are Presented as Mean ± SD, Median (Range), or n (%)

From: Reoperation for isolated rheumatic tricuspid regurgitation

Characteristics All patients n = 26 TV repair n = 15 TV replacement n = 11 p-Value
Ventilator support (hours) 12.5 (3–120) 9 (3–96) 17 (4–120) 0.47
ICU stay (hours) 71.4 ± 38.8 73.1 ± 44.4 69 ± 31.6 0.79
Postoperative stay (days) 16.9 ± 10.1 14.7 ± 10.8 19.8 ± 8.7 0.21
30-day mortality 4 (15.4%) 3 (20%) 1 (9.1%) 0.61
Low cardiac output syndrome 7 (26.9%) 4 (26.7%) 3 (27.3%) 1
Transitory renal failure 8 (30.8%) 5 (33.3%) 3 (27.3%) 0.54
Pneumonia 6 (23.1%) 4 (26.7%) 2 (18.2%) 1
Red Blood Cells transfusion > 1 unit 10 (55.6%) 5 (41.7%) 5 (83.3%) 0.15
Bleeding 6 (23.1%) 4 (26.7%) 2 (18.2%) 1
Reexploration for bleeding 3 (11.5%) 2 (13.3%) 1 (9.1%) 0.62
Sternal wound infection 1 (3.8%) 1 (6.7%) 0 (0%) 0.58
Sepsis 2 (7.7%) 1 (6.7%) 1 (9.1%) 1
Cardiac complication 11 (42.3%) 6 (40%) 5 (45.5%) 1
Respiratory complication 7 (26.9%) 4 (26.7%) 3 (27.3%) 0.66
Infective complication 7 (26.9%) 4 (26.7%) 3 (27.3%) 1
Renal complication 8 (30.8%) 5 (33.3%) 3 (27.3%) 1
Neurologic complications 1 (3.8%) 1 (6.7%) 0 (0%) 1
  1. TV: tricuspid valve, TVrp: tricuspid valve repair, TVR: tricuspid valve replacement, ICU: intensive care unit